Submenu
ABOUT US
OUR SCIENCE
CLINICAL TRIALS
NEWS
CAREERS
FOR PATIENTS
LERAPOLTUREV MOA
PUBLICATIONS
Our Science

PUBLICATIONS

Featured Publication
April 2021
Phase 1 trial of intratumoral PVSRIPO in patients with unresectable, treatment-refractory melanoma
Beasley GM, Nair SK, Farrow NE, et al.

J Immunother Cancer. 2021;9(4):e002203.

Download PDF
March 2022
Intratumoral recall of childhood vaccine-specific CD4+ T cells coordinates Type I and II antitumor immunity
Brown MC, McKay ZP, Yang Y, et al.

bioRxiv preprint doi: https://doi.org/10.1101/2022.03.14.484260

Download PDF
March 2021
Viral infection of cells within the tumor microenvironment mediates antitumor immunotherapy via selective TBK1-IRF3 signaling
Brown MC, Mosaheb MM, Mohme M, et al.

Nat Commun. 2021;12(1):1858.

Download PDF
June 2020
CReP mediates selective translation initiation at the endoplasmic reticulum
Kastan JP, Dobrikova EY, Bryant JD, Gromeier M.

Sci Adv. 2020;6(23):eaba0745.

Read More
January 2020
Genetically stable poliovirus vectors activate dendritic cells and prime antitumor CD8 T cell immunity
Mosaheb MM, Dobrikova EY, Brown MC, et al.

Nat Commun. 2020;11(1):524.

Download PDF
July 2018
Recurrent glioblastoma treated with recombinant poliovirus
Desjardins A, Gromeier M, Herndon JE II, et al.

N Engl J Med. 2018;379(2):150-161.

Download PDF
September 2017
Cancer immunotherapy with recombinant poliovirus induces IFN-dominant activation of dendritic cells and tumor antigen-specific CTLs
Brown MC, Holl EK, Boczkowski D, et al.

Sci Transl Med. 2017;9(408):eaan4220.

Read More